The Pennant Group, Inc.
HealthcareNASDAQ:PNTG · NASDAQ Global Select
+$0.07 today
Vol 0.32M · Avg 0.25M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
8.9%
avg 10.0%
ROIC
4.5%
avg 6.1%
ROA
3.1%
avg 4.1%
Analysis
ROE is currently the strongest return metric at 8.9% versus its period average of 10.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Brent J. Guerisoli | Chief Executive Officer & Chairman | $2.19M | — | 45 | $97,679.00 | 0.28% |
John J. Gochnour | President & Chief Operating Officer | $1.97M | — | 42 | $172,665.00 | 0.50% |
Lynette Walbom | Chief Financial Officer | $1.52M | — | 48 | $34,000.00 | 0.10% |
Jason Steik | Chief Clinical Officer | $1.32M | — | 42 | $0.00 | <0.01% |
Kirk Cheney | Executive Vice President, General Counsel & Corporate Secretary | $1.15M | — | 44 | $0.00 | <0.01% |
Andrew Rider | President of Pinnacle Senior Living LLC | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
6
$271,910.32
Net Sentiment
$271,910.32
Net selling
Most Active
Guerisoli Brent
5 transactions
Analysis
Insiders reported 0 buys worth $0.00 and 6 sells worth $271,910.32 over the last 12 months. That adds up to net selling of $271,910.32. Guerisoli Brent was the most active insider with 5 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +14.1% | +17.7% (8yr)2 analysts |
| Revenue | N/A | N/A | +15.9% | +16.2% (8yr)2 analysts |
| Net Income | N/A | N/A | +16.9% | +20.1% (8yr)2 analysts |
| EBIT | N/A | N/A | +7.1% | +13.1% (8yr)2 analysts |
Analysis
Recent growth has been strongest in Net Income at +16.9% over three years. Forward estimates point to Net Income at +20.1% (8yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Integra LifeSciences Holdings Corporation
NASDAQ:IART
$1.38B
InnovAge Holding Corp.
NASDAQ:INNV
$1.24B
AMN Healthcare Services, Inc.
NYSE:AMN
$1.19B
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
$1.19B
EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
$1.09B
Kura Oncology, Inc.
NASDAQ:KURA
$803.41M
HealthStream, Inc.
NASDAQ:HSTM
$763.39M
Sonida Senior Living, Inc.
NYSE:SNDA
$700.96M
CorMedix Inc.
NASDAQ:CRMD
$685.67M
ProKidney Corp.
NASDAQ:PROK
$242.99M
Who manages PNTG?
The Pennant Group, Inc. (PNTG) lists 6 active executives. The top listed executive is Andrew Rider, President of Pinnacle Senior Living LLC.
Are PNTG insiders buying or selling?
Recent insider activity shows net buying of $11.67M.
Explore More
Continue the stock analysis
Jump to another research area for this company.